Castelli, S.; Thorwarth, A.; van Schewick, C.; Wendt, A.; Astrahantseff, K.; Szymansky, A.; Lodrini, M.; Veldhoen, S.; Gratopp, A.; Mall, M.A.;
et al. Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma. J. Clin. Med. 2024, 13, 5995.
https://doi.org/10.3390/jcm13195995
AMA Style
Castelli S, Thorwarth A, van Schewick C, Wendt A, Astrahantseff K, Szymansky A, Lodrini M, Veldhoen S, Gratopp A, Mall MA,
et al. Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma. Journal of Clinical Medicine. 2024; 13(19):5995.
https://doi.org/10.3390/jcm13195995
Chicago/Turabian Style
Castelli, Sveva, Anne Thorwarth, Claudia van Schewick, Anke Wendt, Kathy Astrahantseff, Annabell Szymansky, Marco Lodrini, Simon Veldhoen, Alexander Gratopp, Marcus A. Mall,
and et al. 2024. "Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma" Journal of Clinical Medicine 13, no. 19: 5995.
https://doi.org/10.3390/jcm13195995
APA Style
Castelli, S., Thorwarth, A., van Schewick, C., Wendt, A., Astrahantseff, K., Szymansky, A., Lodrini, M., Veldhoen, S., Gratopp, A., Mall, M. A., Eggert, A., & Deubzer, H. E.
(2024). Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma. Journal of Clinical Medicine, 13(19), 5995.
https://doi.org/10.3390/jcm13195995
